Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last SR46.20 SAR
Change Today +0.86 / 1.90%
Volume 2.5M
SPIMACO On Other Exchanges
Saudi Arabia
As of 6:49 AM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

saudi pharmaceutical industr (SPIMACO) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/9/14 - SR55.25
52 Week Low
12/17/14 - SR27.60
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

saudi pharmaceutical industr (SPIMACO) Related Businessweek News

No Related Businessweek News Found

saudi pharmaceutical industr (SPIMACO) Details

Saudi Pharmaceutical Industries & Medical Appliances Corporation develops, manufactures, and sells pharmaceutical products and medical appliances in the Kingdom of Saudi Arabia and internationally. It provides anti allergic, antifungal, antiviral, bronchodilator, cardiovascular, anti diabetic, gastrointestinal, and antibiotic drugs; cold and cough preparations; and nasal decongestant products. The company offers its products in various dosage forms comprising tablets and capsules, dry powder, syrups, suspensions, injections, creams, ointments, gels, suppositories, and mouthwash and antiseptic products. Saudi Pharmaceutical Industries & Medical Appliances Corporation was founded in 1986 and is based in Riyadh, the Kingdom of Saudi Arabia.

Founded in 1986

saudi pharmaceutical industr (SPIMACO) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

saudi pharmaceutical industr (SPIMACO) Key Developments

Saudi Pharmaceutical Industries & Medical Appliances Corporation Recommends Dividend for the Year 2014

The Board of Directors of Saudi Pharmaceutical Industries & Medical Appliances Corporation has recommended distribution of cash dividend of SAR 1.5 per share to stockholders for financial year 2014. Total amount of distribution of dividend SAR 180 million.

SPIMACO Announces Earnings Results for the Quarter and Current Period Ended December 31, 2014

SPIMACO announced earnings results for the quarter and current period ended December 31, 2014. For the quarter, net profit was SAR 91.3 million against SAR 57 million a year ago. Operational profit was SAR 89.7 million against SAR 60.2 million a year ago. The increase in profit was due to sales raise of nearly 12%, and rationalize operating costs. For the current period, net profit was SAR 316.9 million against SAR 266.8 million a year ago. Operational profit was SAR 241.9 million against SAR 205.6 million a year ago. The increase in profit was due to sales rise of nearly 12%, in addition to increase the company's income of dividend investee companies. Earnings per share were SAR 2.94 against SAR 3.4 a year ago.

SPIMACO Signs an Agreement with F. Hoffmann-La Roche

Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) signed an agreement with Swiss global healthcare company F. Hoffmann-La Roche on Jan. 13, 2015. The contract is for five years with a renewal option. Under this agreement, SPIMACO will undertake the partial manufacturing, selling and distribution of Herceptin and Mabthera products in Saudi Arabia, considered as the most important products for treating breast cancer.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SPIMACO:AB SR46.20 SAR +0.86

SPIMACO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SPIMACO.
View Industry Companies

Industry Analysis


Industry Average

Valuation SPIMACO Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 16.7x
TEV/Sales 3.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAUDI PHARMACEUTICAL INDUSTR, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at